Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M A, Solinís"'
Autor:
Javier Beitia, Inês Amaral, Ana del Pozo-Rodríguez, Mª Luz Fidalgo, M. Angeles Solinís, M.ª Isabel Rodríguez Fidalgo
Publikováno v:
ICERI Proceedings.
Publikováno v:
Revista Española de Quimioterapia
Objectives To evaluate, by applying pharmacokinetic/pharmacodynamic (PK/PD) analysis, if the change in antibiotic susceptibility after the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in Spain had any influence on the usefulness
Autor:
José Luis Pedraz, Begoña Calvo, M. Dolores Gurruchaga, Isabel Goñi, Alicia R. Gascón, Rosa Maria Hernandez, Yaimy de la Cruz, M. Angeles Solinís
Publikováno v:
Chirality. 14:806-813
We studied the release of salbutamol and ketoprofen enantiomers from HPMC K100M matrices containing two types of cellulose derivatives: cellulose tris (3,5-dimethylphenylcarbamate) and cellulose tris (2,3-dichlorophenylcarbamate), chiral excipients u
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 95
Gene therapy to treat ocular disorders is still starting, and current therapies are primarily experimental, with most human clinical trials still in research state, although beginning to show encouraging results. Currently 33 clinical trials have bee
Autor:
Unax, Lertxundi, Saioa, Domingo-Echaburu, Irati, Irigoyen, Arantxa, Isla, M Ángeles, Solinís, Juan C, García-Moncó
Publikováno v:
Revista de neurologia. 58(8)
Patients with Parkinson's disease (PD) are admitted to hospital more frequently and for a longer time than other patients from the same age group. The reason they are hospitalised is often different from their underlying baseline disease and they are
Publikováno v:
International journal of pharmaceutics. 465(1-2)
The introduction of therapeutic genes in target tissues is considered as a novel tool for the treatment of several diseases. We have developed nanoparticles consisting on SLNs, protamine (P) and hyaluronic acid (HA) as carrier for gene therapy. Stabl
Autor:
Alicia Rodríguez-Gascón, Artur Bartkowiak, Ana del Pozo-Rodríguez, M. Angeles Solinís, Diego Delgado
Publikováno v:
ResearcherID
In the present work, we evaluated the potential utility for gene delivery of three oligochitosans (OligoCh) that differs in the M(n) (OligoChA: 6.1 kDa, OligoChB: 11.5 kDa, and OligoChC: 13.7 kDa), with deacetylation degree of 85%. OligoCh were compl
Publikováno v:
International journal of clinical pharmacology and therapeutics. 42(6)
The relative bioavailability of a new 750 mg tablet formulation of ciprofloxacin (test formulation supplied by Dr. August Wolff GmbH and Co., Germany) was compared with that of Ciprobay tablets 750 mg (reference formulation from Bayer Vital GmbH and
Autor:
M Angeles, Solinís, Yaimy, de la Cruz, Begoña, Calvo, Rosa M, Hernández, Alicia R, Gascón, Isabel, Goñi, M Dolores, Gurruchaga, José Luis, Pedraz
Publikováno v:
Chirality. 14(10)
We studied the release of salbutamol and ketoprofen enantiomers from HPMC K100M matrices containing two types of cellulose derivatives: cellulose tris (3,5-dimethylphenylcarbamate) and cellulose tris (2,3-dichlorophenylcarbamate), chiral excipients u